"cdc25 Phosphatases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of dual specificity phosphatases that play a role in the progression of the CELL CYCLE. They dephosphorylate and activate CYCLIN-DEPENDENT KINASES.
| Descriptor ID |
D020687
|
| MeSH Number(s) |
D08.811.277.352.650.625.225.100 D08.811.277.352.650.775.250.100 D08.811.641.755.100 D12.644.360.268.100 D12.776.167.100 D12.776.476.268.100
|
| Concept/Terms |
cdc25 Phosphatases- cdc25 Phosphatases
- Phosphatases, cdc25
- cdc25 Phosphatase
- Phosphatase, cdc25
cdc25B Phosphatase- cdc25B Phosphatase
- Phosphatase, cdc25B
- M-Phase Inducer Phosphatase 2
- M Phase Inducer Phosphatase 2
- Dual Specificity Phosphatase Cdc25B
- Cell Division Cycle 25B protein
cdc25C Phosphatase- cdc25C Phosphatase
- Phosphatase, cdc25C
- Dual Specificity Phosphatase Cdc25C
- M-Phase Inducer Phosphatase 3
- M Phase Inducer Phosphatase 3
cdc25A Phosphatase- cdc25A Phosphatase
- Phosphatase, cdc25A
- Dual Specificity Phosphatase Cdc25A
- M-Phase Inducer Phosphatase 1
- M Phase Inducer Phosphatase 1
|
Below are MeSH descriptors whose meaning is more general than "cdc25 Phosphatases".
Below are MeSH descriptors whose meaning is more specific than "cdc25 Phosphatases".
This graph shows the total number of publications written about "cdc25 Phosphatases" by people in this website by year, and whether "cdc25 Phosphatases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2010 | 1 | 1 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "cdc25 Phosphatases" by people in Profiles.
-
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers. Sci Rep. 2016 10 24; 6:35854.
-
Anti-Colon Cancer Effects of 6-Shogaol Through G2/M Cell Cycle Arrest by p53/p21-cdc2/cdc25A Crosstalk. Am J Chin Med. 2015; 43(4):743-56.
-
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma. Lung Cancer. 2014 Sep; 85(3):429-34.
-
Schedule-dependent effects of kappa-selenocarrageenan in combination with epirubicin on hepatocellular carcinoma. Asian Pac J Cancer Prev. 2014; 15(8):3651-7.
-
Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C. Cancer Res. 2010 Jun 15; 70(12):5085-95.
-
Cdk2 is required for p53-independent G2/M checkpoint control. PLoS Genet. 2010 Feb 26; 6(2):e1000863.
-
Role of cellular phosphatase cdc25C in herpes simplex virus 1 replication. J Virol. 2008 May; 82(9):4527-32.
-
The interaction of herpes simplex virus 1 regulatory protein ICP22 with the cdc25C phosphatase is enabled in vitro by viral protein kinases US3 and UL13. J Virol. 2008 May; 82(9):4533-43.
-
Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice. Cancer Res. 2007 Jul 15; 67(14):6605-11.
-
Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer. 2006 Dec 29; 5:76.